Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 2Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Ewing 1Neoplasm Metastasis 1Endometrial Neoplasms 1Carcinoma, Transitional Cell 1

Interventions

selinexor 1liposomal doxorubicin 1ixazomib 1fludarabine phosphate 1Temozolomide 1PM 01183 1Melphalan 1Irinotecan 1Erlotinib Hydrochloride 1Electroacupuncture 1Busulfan 1Biopsy, Fine-Needle 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Sarcoma, Ewing × PM 01183 × Clear all
NCT05042934 2022-02-10

Lurbinectedin With or Without Irinotecan in Treating Patients With Relapsed or High Risk Metastatic Ewing Sarcoma

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Sarcoma

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡